Anthropic Ships Sonnet 5 With Agentic Safety and Pricing Details
1 July 20265 min read
Medicine
FDA Updates Clinical Decision Support Software FAQ as AI Tools Move Deeper Into Care
The FDA updated its clinical decision support software FAQ, clarifying how software functions may fall outside device regulation, receive enforcement discretion or remain subject to oversight.
Illustrative image. Cedar S. Insights uses editorial stock photography; images do not depict specific events described in articles.
The FDA updated its Clinical Decision Support Software Frequently Asked Questions page on 29 June, adding practical explanations for developers and sponsors trying to determine whether software functions are medical devices.
The agency says clinical decision support software can be important in modern healthcare, but not every tool described as decision support is regulated in the same way. Some functions may be excluded from the device definition, some may fall under enforcement discretion and others remain device functions subject to FDA oversight.
The FAQ discusses simple calculations, time-critical settings, multi-function products, platforms that host user-developed CDS tools, and predictive decision support interventions connected to ONC health IT rules.
Sourcing note: The update is FDA guidance-style explanatory material. It clarifies regulatory interpretation but does not itself approve, clear or validate any specific clinical AI or software product.
Why It Matters
Clinical AI often enters hospitals as decision support rather than as a standalone device. Clearer boundaries around CDS software help determine which tools require formal medical-device controls and which remain lower-risk workflow support.
What to Watch
Watch how FDA applies CDS distinctions to predictive and generative AI tools, especially where outputs are time-critical, opaque, highly automated or presented as a single clinical recommendation.
Primary Sources
Our sourcing: Cedar S. Insights provides source-led editorial analysis. Reported company, institutional and regulatory claims are attributed to their original sources unless stated otherwise.
Corrections: If a material factual error is identified, Cedar S. Insights will update the relevant article and preserve the distinction between the corrected statement and supporting evidence.
Topics
FDAClinical Decision SupportSoftware as a Medical DeviceDigital HealthHealthcare AI